期刊文献+

肌肉特异性受体酪氨酸激酶抗体阳性重症肌无力 被引量:13

Myasthenia gravis with muscle specific receptor tyrosine kinase antibodies
原文传递
导出
摘要 目的 探讨不同血清抗体重症肌无力(MG)的临床特征.方法 用荧光免疫沉淀法(FIPA)和荧光免疫细胞染色法(CBA)检测119例MG患者血清乙酰胆碱受体抗体(AChR-Ab)和肌肉特异性受体酪氨酸激酶抗体(MuSK-Ab)水平.比较AChR-Ab阳性、MuSK-Ab阳性、血清抗体阴性MG的临床特征.结果 纳入119例患者中,90例AChR-Ab阳性(75.6%),29例阴性:其中5例MuSK-Ab阳性(17.2%),24例血清抗体阴性(82.8%).AChR-Ab阳性、MuSK-Ab阳性和血清抗体阴性MG 3组比较,男女比例和平均发病年龄差异均无统计学意义.3例MuSK-Ab阳性的患者主要表现为延髓肌受累;79.2%(19/24)的血清抗体阴性MG患者表现为美国MG协会(MGFA)Ⅰ型;2例MuSK-Ab阳性的患者MGFA≥Ⅲ型;MuSK-Ab滴度水平与患者病情严重程度相关(r=0.941,P=0.014);MuSK-Ab阳性的患者均未发现有胸腺的异常.结论 MuSK-Ab仅出现在AChR-Ab阴性患者的血清中.MuSK-Ab阳性的患者主要表现为延髓肌受累,病情较重且不伴有胸腺的病变.MuSK-Ab阳性的MG可能是不同于血清AChR-Ab阳性的MG的又一亚型. Objectives To compare the characteristics of myasthenia gravis (MG) with different antibodies.Methods The muscle specific receptor tyrosine kinase (MuSk) and acetylcholine receptor (AChR) antibodies were detected in the sera of 119 MG patients,and fluoroimmunoprecipitation assay and cell based assay were applied. The clinical features of AChR-Ab positive,MuSK-Ab positive and serum negative MG patients were compared.Results There were 90 AChR-Ab positive sera tested out from the 119 MG sera,and 5 sera found with MuSK-Ab in the 29 AChR-Ab negative sera.There was no significant difference among the three groups regarding sex and age at onset.There were 3/5 of MuSK-Ab positive patients with predominantly bulbar paralysis,2/5 of MuSK-Ab positive patients were classified as MGFA Ⅲ to Ⅴ,and 79.2% (19/24) of serum negative patients were classified as MGFA Ⅰ.There was significantly positive relation between the levels of MuSK antibodies and disease severity (r=0.941,P=0.014).Neither thymic hyperplasia nor hymoma were found in MuSK-Ab positive patients.Conclusions MuSK antibodies are only detected out in the sera without AChR-Ab.The MuSK-Ab positive patients are mainly involved bulbar muscles,and without thymus abnormality.MuSK-MG is different with the AChR MG.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2010年第11期770-773,共4页 Chinese Journal of Neurology
关键词 重症肌无力 受体蛋白质酪氨酸激酶类 荧光免疫测定 Myasthenia gravis Receptor protein-tyrosine kinases Fluoroimmunoassay
  • 相关文献

参考文献25

  • 1Lindstrom JM,Seybold ME,Lennon VA,et al.Antibody to acetylcholine receptor in myasthenia gravis.Prevalence,clinical correlates,and diagnostic value.Neurology,1976,26:1054-1059.
  • 2Hoch W,McConville J,Helms S,et al.Auto-antibodies to the receptor tyrosine kinsase MuSK in patients with myasthenia gravis,without acetylcholine receptor antibodies.Nat Med,2001,7:365-368.
  • 3Zhou L,McConville J,Chaudhry V,et al.Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and-negative myasthenic patients.Muscle Nerve,2004,30:55-60.
  • 4Evoli A,Tonali PA,Padua L,et al.Clinical correlates with antiMuSK antibodies in generalized seronegative myasthenia gravis.Brain,2003,126 Pt 10:2304-2311.
  • 5Stickler DE,Massey JM,Sanders DB.MuSK-antibody positive myasthenia gravis:clinical and electrodiagnostic patterns.Clin Neurophysiol,2005,116:2065-2068.
  • 6McConville J,Farrugia ME,Beeson D,et al.Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.Ann Neurol,2004,55:580-584.
  • 7Lavrnic D,Losen M,Vujic A,et al.The features of myasthenia gravis with autoantibodies to MuSK.J Neurol Neurosurg Psychiatry,2005,76:1099-1102.
  • 8王化冰,刘明生,崔丽英.重症肌无力抗肌肉特异性酪氨酸受体激酶抗体阳性一例[J].中华神经科杂志,2006,39(5):354-354. 被引量:5
  • 9宋金辉,徐金枝.重症肌无力患者酪氨酸激酶抗体的检测[J].中国神经免疫学和神经病学杂志,2006,13(1):9-10. 被引量:7
  • 10Leite MI,Jacob S,Viegas S,et al.IgG1 antibodies to acetylcholine receptors in 'seronegative'myasthenia gravis.Brain,2008,5:1-13.

二级参考文献21

  • 1崔丽英,李延峰,李永红,张俊保.重症肌无力患者血清兰尼定碱受体抗体的测定及临床意义[J].中国医学科学院学报,2007,29(2):238-240. 被引量:2
  • 2袁必文 周鸣生 李克.HLA与重症肌无力相关的研究[J].遗传与疾病,1987,4:129-129.
  • 3Sanders DB, El-Salem K, Massey JM, et al. Clinical aspects of MuSK antibody positive seronegative MG [J]. Nemology, 2003, 60(12) :1978-1980.
  • 4Vincent A, McConville J, Farrugia ME, et al.Seronegative Myasthenia Gravis[J]. Semin Neurol,2004 Mar, 24(1) :125-133.
  • 5Vincent A, Bowen J, Newsom-Davis J, et al.Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets [J]. Lancet Neurol, 2003, 2(2):99-106.
  • 6Matthews I, Chen S, Hewer R, etal. Muscle-specific receptor tyrosine kinase autoantibody-a new immunoprecipitation assay[J]. Clin Chim Acta, 2004,348(1-2):95-99.
  • 7Yeh JH, Chen WH, Chiu HC, et al. Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese [J]. Neurology,2004, 62(11):2131-2132.
  • 8McConville J, Farrugia ME, Beeson D, et al.Detection and characterization of MuSK antibodies in seronegative myasthenia gravis [J]. Ann Neurol,2004, 55(4):580-584.
  • 9Dawkins RL. HLA and disease susceptibility [J].Immunol Rev, 1983, 70:1-218.
  • 10徐星培 汪超英 郑从义.HLA与重症肌无力相关的研究[J].中国神经精神疾病杂志,1985,11:68-68.

共引文献26

同被引文献157

引证文献13

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部